Cargando…
A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poiso...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413541/ https://www.ncbi.nlm.nih.gov/pubmed/22828054 http://dx.doi.org/10.1186/1757-7241-20-49 |
_version_ | 1782240073749626880 |
---|---|
author | Lund, Cathrine Drottning, Per Stiksrud, Birgitte Vahabi, Javad Lyngra, Marianne Ekeberg, Ivind Jacobsen, Dag Hovda, Knut Erik |
author_facet | Lund, Cathrine Drottning, Per Stiksrud, Birgitte Vahabi, Javad Lyngra, Marianne Ekeberg, Ivind Jacobsen, Dag Hovda, Knut Erik |
author_sort | Lund, Cathrine |
collection | PubMed |
description | OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poisonings in adults (≥16 years) admitted to the five hospitals in Oslo were included consecutively during one year (2008 to 2009) in an observational cross-sectional multicenter study. A standardized form was completed by the treating physician, which covered the study aims. RESULTS: There were 1065 admissions in 912 patients. The median length of hospital stay was one day, and 49% were observed in an intensive care unit (ICU). Active treatment was given to 83%, and consisted of supportive therapy (70%), antidote(s) (38%), activated charcoal (16%) and gastric lavage (9%). The most commonly used antidotes were flumazenil (19%), naloxone (17%) and N-acetylcysteine (11%). The rate of treatment-related complications was 2.4% (21/884). Neither flumazenil, naloxone, nor the combination, was associated with convulsions or other complications. Among those receiving N-acetylcysteine, 5% (6/120) developed allergic reactions, one of which mandated discontinuation of treatment. Nineteen percent presented in a coma. Complications developed in 30%, compared with 18% in a 2003 study, mainly respiratory depression (12%), prolonged QTc interval (6%) and hypotension (5%). Eight patients died (0.8%) and five (0.5%) survived with permanent sequelae, mainly anoxic brain damage. DISCUSSION: Few patients stayed more than two days. The use of the ICU was liberal, considering that only one out of five presented in a coma. Antidotes were frequently given diagnostically. Although N-acetylcysteine induced allergic reactions, most were mild and treatment discontinuation was only necessary once. The frequency of complications had almost doubled in five years, although the poisoning pattern was largely unchanged. However, few patients developed permanent sequelae. |
format | Online Article Text |
id | pubmed-3413541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34135412012-08-08 A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae Lund, Cathrine Drottning, Per Stiksrud, Birgitte Vahabi, Javad Lyngra, Marianne Ekeberg, Ivind Jacobsen, Dag Hovda, Knut Erik Scand J Trauma Resusc Emerg Med Original Research OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poisonings in adults (≥16 years) admitted to the five hospitals in Oslo were included consecutively during one year (2008 to 2009) in an observational cross-sectional multicenter study. A standardized form was completed by the treating physician, which covered the study aims. RESULTS: There were 1065 admissions in 912 patients. The median length of hospital stay was one day, and 49% were observed in an intensive care unit (ICU). Active treatment was given to 83%, and consisted of supportive therapy (70%), antidote(s) (38%), activated charcoal (16%) and gastric lavage (9%). The most commonly used antidotes were flumazenil (19%), naloxone (17%) and N-acetylcysteine (11%). The rate of treatment-related complications was 2.4% (21/884). Neither flumazenil, naloxone, nor the combination, was associated with convulsions or other complications. Among those receiving N-acetylcysteine, 5% (6/120) developed allergic reactions, one of which mandated discontinuation of treatment. Nineteen percent presented in a coma. Complications developed in 30%, compared with 18% in a 2003 study, mainly respiratory depression (12%), prolonged QTc interval (6%) and hypotension (5%). Eight patients died (0.8%) and five (0.5%) survived with permanent sequelae, mainly anoxic brain damage. DISCUSSION: Few patients stayed more than two days. The use of the ICU was liberal, considering that only one out of five presented in a coma. Antidotes were frequently given diagnostically. Although N-acetylcysteine induced allergic reactions, most were mild and treatment discontinuation was only necessary once. The frequency of complications had almost doubled in five years, although the poisoning pattern was largely unchanged. However, few patients developed permanent sequelae. BioMed Central 2012-07-24 /pmc/articles/PMC3413541/ /pubmed/22828054 http://dx.doi.org/10.1186/1757-7241-20-49 Text en Copyright ©2012 Lund et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Lund, Cathrine Drottning, Per Stiksrud, Birgitte Vahabi, Javad Lyngra, Marianne Ekeberg, Ivind Jacobsen, Dag Hovda, Knut Erik A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title | A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title_full | A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title_fullStr | A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title_full_unstemmed | A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title_short | A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae |
title_sort | one-year observational study of all hospitalized acute poisonings in oslo: complications, treatment and sequelae |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413541/ https://www.ncbi.nlm.nih.gov/pubmed/22828054 http://dx.doi.org/10.1186/1757-7241-20-49 |
work_keys_str_mv | AT lundcathrine aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT drottningper aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT stiksrudbirgitte aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT vahabijavad aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT lyngramarianne aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT ekebergivind aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT jacobsendag aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT hovdaknuterik aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT lundcathrine oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT drottningper oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT stiksrudbirgitte oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT vahabijavad oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT lyngramarianne oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT ekebergivind oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT jacobsendag oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae AT hovdaknuterik oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae |